IndraLab

Statements

Sulfamethoxazole activates ATXN3. 1 / 1

| 1

reach

"Encouraged by previous publications reporting some improvement in spasticity and gait in two patients with MJD treated with sulphamethoxazole and trimethoprim (Bactrim), we carried out a double-blind, placebo controlled cross-over trial in eight patients."

8597984

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Sulfamethoxazole activates ATXN3. 1 / 1

INDRA sources:

Databases

Reading